Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sublingual
Pharma
Sublingual psychedelic startup nets $60M for depression trials
Investors are betting that sublingual drug delivery can unlock the potential of a psychedelic, pumping $60 million into Lusaris to support trials.
Nick Paul Taylor
Nov 8, 2022 7:30am
Sublingual delivery firm hits back against SEC fraud complaint
Oct 4, 2022 7:30am
Seelos eyes chronic ketamine dosing with sublingual candidate
Nov 30, 2021 9:45am
Stallergenes taps Aptar for connected drug delivery project
Nov 1, 2021 12:22pm
Sunovion cashes in Parkinson's drug, selling EU rights
Sep 7, 2021 7:45am
FDA shares advice on bioequivalence of different dosage forms
Aug 24, 2021 7:45am
